Epigenome Technologies
UEI: LS7JQN77JKQ1
• CAGE: 8Q3M2
Overview
Awardee Type
Parent
Federal Capability Statement
A small woman owned company specialized in single cell multi-omics sequencing applied to cancer research.
Keywords
Biomarker, cancer, epigenetics, single cell, multi-omics, research, biotechnology, sequencing
SBA Special Equipment
None.
Headquarters
San Diego, CA
United States
United States
Most Recent Award
Sept. 25, 2023
Calculating
Federal contract and grant recipient
EPIGENOME TECHNOLOGIES, INC.
(UEI LS7JQN77JKQ1, CAGE 8Q3M2)
is headquartered in San Diego CA.
Its primary registered NAICS is 541714 Research and Development in Biotechnology (except Nanobiotechnology).
The corporation
was founded in July 2020 and
federally registered in
August 2020.
Federal Award Analysis
Epigenome Technologies federal award history
$-
Contracts
$-
Subcontracts
$-
Grants
$-
Subgrants
$-
Total
No Results
Calculating
Calculating
No Results
Calculating
Calculating
No Results
Calculating
Calculating
| Year | Contracts | Subcontracts | Grants | Subgrants |
|---|
No Results
Calculating
Calculating
No Results
Calculating
Calculating
Federal Registration and Certifications
Legal Name
EPIGENOME TECHNOLOGIES, INC.
UEI
LS7JQN77JKQ1
CAGE Code
8Q3M2
SBA Certifications
None
Self Certifications
For Profit Organization
Entity Structure
Corporate Entity (Not Tax Exempt)
Purpose of Registration
Federal Contracts and Assistance
Date Founded
July 29, 2020
Initial Registration
Aug. 26, 2020
Last Registration
July 16, 2025
Registration Activation
July 16, 2025
Registration Expiration
July 14, 2026
Fiscal Year End
December 31
Reported Entity Types
For Profit Organization
State of Incorporation
DE
Country of Incorporation
USA
Employees
<500
Reported PSC
Accepts Credit Cards
No